Cardio Diagnostics Shares Rise 4.9% Amid AI‑Driven Cardiac Tech Upside
Cardio Diagnostics’ AI‑powered genetic engine sees a 4.88% share jump, offering investors a glimpse of growth amid a volatile biotech market.
- CARDIO DIAGNOSTICS HOLDINGS
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read